ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth
NAV
₹43.6400
as of 31 Jul 2026
Expense Ratio
1.86%
AUM
₹6,476 Cr
Lumpsum returns (CAGR)
- 1Y
- +6.28%
- 3Y
- +22.95%
- 5Y
- +15.78%
- Since Inception
- +20.09%
SIP returns (XIRR)
- 1Y
- +18.00%
- 3Y
- +17.71%
- 5Y
- +20.25%
- Since Inception
- +21.40%
What history actually did — last 8 years (Aug 2018 – Jul 2026)
A ₹5,000 monthly SIP for the last 8 years (Aug 2018 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹11,28,735 today — ₹4,75,000 invested, 21.4% XIRR.
₹4,75,000
Invested
₹11,28,735
Value today
21.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 8 years (Aug 2018 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 8 years ago would be ₹4,27,424 today (19.9% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2018 would still hold ₹31,45,506.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹11,28,735 in this fund vs ₹8,49,456 in the benchmark — outperformance of ₹2,79,279.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 8 years (Aug 2018 – Jul 2026) (22 Mar 2020) would be ₹4,93,665 today (4.94×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.30
Sharpe Ratio
+0.07
Alpha
0.22
Beta
0.29
Sortino
14.52%
Std Dev
-12.27%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology75.78%
- Healthcare Services11.50%
- Retailing5.35%
- Insurance1.33%
- Chemicals & Petrochemicals1.33%
- Healthcare Equipment & Supplies0.77%
Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.12.20%
- 2Dr. Reddy'S Laboratories Ltd.8.22%
- 3Mankind Pharma Ltd.6.98%
- 4Cipla Ltd.6.67%
- 5Alkem Laboratories Ltd.5.67%
- 6Divi'S Laboratories Ltd.5.57%
- 7Cohance Lifesciences Ltd.4.31%
- 8Medplus Health Services Ltd3.66%
- 9Max Healthcare Institute Ltd3.10%
- 10Syngene International Ltd.2.89%
Investment Objective
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 8 years. It manages assets worth ₹6,476 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.86%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations